Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Jean P Issa

Email
Center AffiliationsCancer Epigenetics

Publications (50) (print view)

no pagination
Yamazaki J, Jelinek J, Lu Y, Cesaroni M, Madzo J, Neumann F, He R, Taby R, Vasanthakumar A, Macrae T, Ostler KR, Kantarjian HM, Liang S, Estecio MR, Godley LA, Issa JP. TET2 mutations affect non-CpG island DNA methylation at enhancers and transcription factor binding sites in chronic myelomonocytic leukemia. Cancer Res. 2015 May 13;75(14):2833-43.   PMCID: 4506197
Yamazaki J, Taby R, Jelinek J, Raynal NJ, Cesaroni M, Pierce SA, Kornblau SM, Bueso-Ramos CE, Ravandi F, Kantarjian HM, Issa JP. Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia. Journal of the National Cancer Institute. 2015 Nov 13;108(2).   PMCID: 4862435
Plimack ER, Desai JR, Issa JP, Jelinek J, Sharma P, Vence LM, Bassett RL, Ilagan JL, Papadopoulos NE, Hwu WJ. A phase I study of decitabine with pegylated interferon α-2b in advanced melanoma: Impact on DNA methylation and lymphocyte populations. Investigational New Drugs. 2014 Oct;32(5):969-75.   PMCID: 4171200
Plimack ER, Desai JR, Issa JP, Jelinek J, Sharma P, Vence LM, Bassett RL, Ilagan JL, Papadopoulos NE, Hwu WJ. A phase I study of decitabine with pegylated interferon alpha-2b in advanced melanoma: impact on DNA methylation and lymphocyte populations. Invest New Drugs. 2014 Oct;32(5):969-75.
Stewart DJ, Nunez MI, Jelinek J, Hong D, Gupta S, Aldaz M, Issa JP, Kurzrock R, Wistuba. Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samples. Clin Epigenetics. 2014 Jan;6(1):13.   PMCID: Pmc4094901
Stewart DJ, Nunez MI, Jelinek J, Hong D, Gupta S, Issa JP, Wistuba, Kurzrock R. Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors. Clin Epigenetics. 2014 Jan;6(1):2.   PMCID: Pmc3895853
Estecio MR, Gallegos J, Dekmezian M, Lu Y, Liang S, Issa JP. SINE retrotransposons cause epigenetic reprogramming of adjacent gene promoters. Molecular cancer research : MCR. 2012 Oct;10(10):1332-42.   PMCID: Pmc3475755
Engstrom PF. Cancer Prevention and Control Priorities for the Year-2000 - a Commentary. Cancer. 1994 Aug 15;74(4):1433-7.
Fan JB, Deyoung J, Lagace R, Lina RA, Xu ZD, Murray JC, Buetow KH, Weissenbach J, Goold RD, Cox DR, Myers RM. Isolation of Yeast Artificial Chromosome Clones from 54 Polymorphic Loci Mapped with High Odds on Human-Chromosome-4. Human molecular genetics. 1994 Feb;3(2):243-6.
Feitelson M, Lega L, Guo JH, Resti M, Rossi ME, Azzari C, Blumberg BS, Vierucci A. Pathogenesis of Posttransfusion Viral-Hepatitis in Children with Beta-Thalassemia. Hepatology (Baltimore, Md). 1994 Mar;19(3):558-68.
Fenning MC, Brown DQ, Chapman JD. Photodosimetry of Interstitial Light Delivery to Solid Tumors. Medical Physics. 1994 Jul;21(7):1149-56.
Flubacher MM, Bear SE, Tsichlis PN. Replacement of Interleukin-2 (Il-2)-Generated Mitogenic Signals by a Mink Cell Focus-Forming (Mcf) or Xenotropic Virus-Induced Il-9-Dependent Autocrine Loop - Implications for Mcf Virus- Induced Leukemogenesis. Journal of Virology. 1994 Dec;68(12):7709-16.
Gasser DL, Sternberg NL, Pierce JC, Goldnersauve A, Feng H, Haq AK, Spies T, Hunt C, Buetow KH, Chaplin DD. P1 and Cosmid Clones Define the Organization of 280 Kb of the Mouse H-2-Complex Containing the Cps-1 and Hsp70 Loci. Immunogenetics. 1994 Jan;39(1):48-55.
Glusker JP. Untitled. Acta Crystallographica Section D-Biological Crystallography. 1994 Jan;50:1.
Johnson SW, Perez RP, Godwin AK, Yeung AT, Handel LM, Ozols RF, Hamilton TC. Role of Platinum-DNA Adduct Formation and Removal in Cisplatin Resistance in Human Ovarian-Cancer Cell-Lines. Biochemical pharmacology. 1994 Feb 11;47(4):689-97.
Johnson SW, Swiggard PA, Handel LM, Brennan JM, Godwin AK, Ozols RF, Hamilton TC. Relationship between Platinum-DNA Adduct Formation and Removal and Cisplatin Cytotoxicity in Cisplatin-Sensitive and Cisplatin-Resistant Human Ovarian-Cancer Cells. Cancer Research. 1994 Nov 15;54(22):5911-6.
Joseph P, Jaiswal AK. Nad(P)H-Quinone Oxidoreductase(1) (Dt Diaphorase) Specifically Prevents the Formation of Benzo a Pyrene Quinone-DNA Adducts Generated by Cytochrome P4501a1 and P450 Reductase. Proceedings of the National Academy of Sciences of the United States of America. 1994 Aug 30;91(18):8413-7.
Joseph P, Jaiswal AK, Stobbe CC, Chapman JD. The Role of Specific Reductases in the Intracellular Activation and Binding of 2-Nitroimidazoles. International Journal of Radiation Oncology Biology Physics. 1994 May 15;29(2):351-5.
Joseph P, Sharma MC, Jaiswal AK. Inhibition of Nad(P)H-Quinone Oxidoreductase(1) in Ethacrynic Acid-Resistant Human Colon-Carcinoma Cells. Biochemical pharmacology. 1994 Jun;47(11):2011-5.
Joseph P, Srinivasan SN, Byczkowski JZ, Kulkarni AP. Bioactivation of Benzo(a)Pyrene-7,8-Dihydrodiol Catalyzed by Lipoxygenase Purified from Human Term Placenta and Conceptal Tissues. Reproductive Toxicology. 1994 Jul;8(4):307-13.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Jean P Issa Sparkline Graph

Graph Interactions

Co-Authors:

Similar Investigators:


Keywords (MeSH):


Last updated on Thursday, November 02, 2017